ENVERIC BIOSCIENCES
Enveric Biosciences is a patient-centric biotechnology company endeavoring to enhance the lives of those who are adversely affected by the side effects of cancer treatments. Enveric Biosciences has set out with the goal of rigorously testing natural compounds, starting with cannabinoids, to provide patients and clinicians with novel prescription medicines to serve these unmet medical needs.
ENVERIC BIOSCIENCES
Industry:
Biotechnology Health Care Life Science Medical
Founded:
1994-01-01
Address:
Naples, Florida, United States
Country:
United States
Website Url:
http://www.enveric.com
Total Employee:
251+
Status:
Active
Contact:
239-302-1707
Email Addresses:
[email protected]
Total Funding:
40.84 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-05-24 | MagicMed Industries | MagicMed Industries acquired by Enveric Biosciences | 4 M CAD |
Key Employee Changes
| Date | New article |
|---|---|
| 2021-12-06 | Enveric Biosciences Appoints Dr. Bob Dagher as Chief Medical Officer |
Official Site Inspections
http://www.enveric.com Semrush global rank: 3.07 M Semrush visits lastest month: 5.26 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Enveric Biosciences"
Company Overview – Enveric Biosciences
Enveric is advancing EB-003, expected to offer a first-in-class, new approach for difficult-to-treat mental health disorders, mediated by the promotion of neuroplasticity without also inducing hallucinations in the patient. Enveric’s …See details»
Enveric Biosciences - Crunchbase Company Profile & Funding
Enveric Biosciences is a patient-centric biotechnology company endeavoring to enhance the lives of those who are adversely affected by the side effects of cancer treatments. Enveric …See details»
Team – Enveric Biosciences
Dr. Jillian Hagel, Vice President of Innovation at Enveric Bioscience, boasts over two decades of experience in biotechnology and biochemistry. ... Dr. Schabacker became president and chief …See details»
Enveric Biosciences - Overview, News & Similar companies
May 20, 2024 Who is Enveric Biosciences. Enveric Biosciences is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the …See details»
Enveric Biosciences, Inc. - LinkedIn
Enveric Biosciences, Inc. | 2,976 followers on LinkedIn. A New Approach to Solving Mental Health Challenges | Enveric Biosciences (NASDAQ: ENVB) is a biotechnology company dedicated to …See details»
Enveric Biosciences, Inc. - LinkedIn
Enveric Biosciences (NASDAQ: ENVB) is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of anxiety, depression, and ...See details»
Enveric Bio - Org Chart, Teams, Culture & Jobs - The Org
View Enveric Bio's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Enveric Biosciences - Funding, Financials, Valuation & Investors
Enveric Biosciences is a patient-first biotechnology company developing rigorously tested, novel cannabinoid medicines. Search Crunchbase. Start Free Trial . ... Which types of acquisition …See details»
Enveric Biosciences, Inc. - Prism MarketView
Jan 2, 2024 Enveric is developing the first product from the EVM201 Series – EB-373 – for the treatment of anxiety disorders. Enveric is also advancing its second program, the EVM301 …See details»
Enveric Biosciences - Craft
Enveric Biosciences Summary. Company Summary. Overview. Enveric Biosciences is a biotechnology company that specializes in drug development solutions. It develops …See details»
Investors – Enveric Biosciences
Dec 2, 2024 Enveric Biosciences is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, …See details»
Enveric Biosciences - VentureRadar
Enveric Biosciences' robust pipeline supports drug development from the clinic to commercialization for millions of patients in need around the world suffering from conditions …See details»
Enveric Biosciences Canada Inc - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Enveric Biosciences Canada Inc of Calgary, AB. Get the latest business insights from Dun & Bradstreet.See details»
Enveric Biosciences - Overview, News & Similar companies
May 20, 2024 Enveric Biosciences to Participate in BIO International Convention 2024 CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” …See details»
Enveric Biosciences - Psychedelic Science Review
Enveric uses PsyAI, an artificial intelligence program, to efficiently identify viable psychedelic pharmaceutical candidates from a “Psybrary” of compounds — a library of psychedelic …See details»
Enveric Biosciences Reports Third Quarter 2024 Financial and …
Nov 14, 2024 A discussion of these and other factors, including risks and uncertainties with respect to Enveric, is set forth in Enveric’s filings with the Securities and Exchange …See details»
Enveric Biosciences Appoints New Independent Directors
Jul 27, 2022 Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a neuroscience-focused biotechnology company developing next-generation, psycheSee details»
Enveric Biosciences Reports Full-Year 2021 Financial Results and ...
Dec 31, 2021 A discussion of these and other factors, including risks and uncertainties with respect to Enveric, is set forth in Enveric’s filings with the Securities and Exchange …See details»
Enveric Biosciences Announces Closing of $10 Million Public Offering
NAPLES, Fla., Feb. 15, 2022 /CNW/ – Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a neuroscience company developing next-generation, psychedelic-inspired …See details»